Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone Replacement for Cancer-related Fatigue in Older Men
NCT04301765Phase 2Active, not recruiting
- Sponsor
- Seattle Institute for Biomedical and Clinical Research
- Start
- Jan 2021
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Testosterone TEPI patch in cancer-related fatigue (CRF), Hypogonadism, sponsored by Seattle Institute for Biomedical and Clinical Research. Started Jan 2021; status: active, not recruiting.
02
Drugs
Testosterone TEPI patch
03
Conditions
cancer-related fatigue (CRF)Hypogonadism
Beyond the preview
Go deeper on NCT04301765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04301765.